This is the week MILV crossed the Rubicon and the Walls at the ask fell.
Makes me think there must be a virus going round turning sellers in buyers?
LOL
Or maybe it is MILV DD???
"One hell of a custodian play that come around once in every 10 or so years. $MILV looks like the real deal.
The neural network that is being weaved as CAA, LLC plans to merge with $MILV is pretty spectacular.
Currently, Compelling Competitive Advantage, Inc (soon to merge with $MILV and change the name to Compelling Competitive Advantage, LLC -- CCA) has an open contract with the University of Pennsylvania and Childrens Hospital of Philadelphia.
The plan is to use one of the major stakeholders patents in liposomal technology (Michael W. Fountain, PhD) to license it for many therapeutic applications. Liposomes are considered "vehicles" for therapeutic agents to get to targeted locations within the body. Michael W. Fountain has developed an ingenious was to make them:
1. Smaller
2. Durable
3. Sustainable (shelf life of 24 months)
4. Develop quickly
Certain stakeholders in the company like "Edward J. Mathias" are the trustee emeritus of UPenn, whom like Ecomike just indicated, is a senior advisor with the Carlyle Group. One of the world's largest investment firms.
Additionally, he has worked with a very prominent banking company known as the Crosshill Financial Group cofounded by another large stakeholder in CCA, Stuart Yarbrough... whom have a history of working together.
Stuart has helped business with $800 million dollars in funding as of 1999. That was 20 years ago!!
CCA Biotech Click Here"
http://ccabiotech.blogspot.com/
Which is in the process of R/M with MILV.
They said it would never break down the .0025 wall with out official news.
They were wrong.
Then the wall at .0030 was nuked in minutes today.
Makes me think there must be a virus going round turning sellers in buyers?
LOL
Or maybe it is MILV DD???
"One hell of a custodian play that come around once in every 10 or so years. $MILV looks like the real deal.
The neural network that is being weaved as CAA, LLC plans to merge with $MILV is pretty spectacular.
Currently, Compelling Competitive Advantage, Inc (soon to merge with $MILV and change the name to Compelling Competitive Advantage, LLC -- CCA) has an open contract with the University of Pennsylvania and Childrens Hospital of Philadelphia.
The plan is to use one of the major stakeholders patents in liposomal technology (Michael W. Fountain, PhD) to license it for many therapeutic applications. Liposomes are considered "vehicles" for therapeutic agents to get to targeted locations within the body. Michael W. Fountain has developed an ingenious was to make them:
1. Smaller
2. Durable
3. Sustainable (shelf life of 24 months)
4. Develop quickly
Certain stakeholders in the company like "Edward J. Mathias" are the trustee emeritus of UPenn, whom like Ecomike just indicated, is a senior advisor with the Carlyle Group. One of the world's largest investment firms.
Additionally, he has worked with a very prominent banking company known as the Crosshill Financial Group cofounded by another large stakeholder in CCA, Stuart Yarbrough... whom have a history of working together.
Stuart has helped business with $800 million dollars in funding as of 1999. That was 20 years ago!!
CCA Biotech Click Here"
http://ccabiotech.blogspot.com/
Which is in the process of R/M with MILV.
They said it would never break down the .0025 wall with out official news.
They were wrong.
Then the wall at .0030 was nuked in minutes today.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
